glp 1 thyroid cancer Glucagon-like peptide-1 medicines and Implications of GLP-1 Receptor Agonist

Semaglutide is contraindicated in patients with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Common Adverse Effects According to clinical trial data, gastrointestinal effects are most frequently reported: nausea, vomiting, diarrhea, constipation, and abdominal discomfort

If your provider determines labs are needed, that cost would be on you separately, but you may be able to use insurance to pay for the lab work

Liraglutide and exenatide have been associated with the development of thyroid C-cell tumors in rodents after lifetime exposure at supratherapeutic doses [169]

many people don't take advantage of benefits their MA plan already offers

and Campbell R